Thursday, July 30, 2026
Biotech

Hims & Hers Faces FTC Lawsuit Due to Data Dealings

Hims & Hers stock dropped 10% after the FTC sued the company over how it handles patient data and billing.

Hims & Hers, a telehealth company, saw its stock fall sharply. The Federal Trade Commission, or FTC, sued them. This lawsuit accuses the company of breaking promises about patient privacy and fair billing.

The FTC claims Hims & Hers shared private health information with social media companies like Meta and Snap. This could be a problem for patient trust. The FTC also looked at how the company charges customers and how easy it is to cancel subscriptions.

The company's stock dropped 10% after this news. This shows how seriously investors take government actions. The case highlights the importance of protecting sensitive patient data. It also points to the need for clear billing practices.

Customers expect their health data to stay private. They also want clear, understandable bills and easy ways to manage subscriptions. This lawsuit reminds all companies in the health tech space to meet these expectations.

Source: CNBC

#Biotech#Hims & Hers#FTC#Lawsuit#Data Privacy

More from Biotech